Hepatitis C

Publication Title: 
Journal of Alternative and Complementary Medicine (New York, N.Y.)

INTRODUCTION: Traditional Chinese Medicine (TCM), a modern interpretation of Chinese medicine, developed in the 1950s. It differentiates biomedical diseases into patterns. Each pattern comprises symptom/signs that have their own unique treatment protocol. Most TCM research has used fixed formula treatments for Western-defined diseases with outcomes often measured using objective biomedical markers. More recently, a number of trials have attempted to accommodate TCM clinical practice within the framework of rigorous evidence-based medical research.

Author(s): 
Berle, Christine A.
Cobbin, Deirdre
Smith, Narelle
Zaslawski, Christopher
Publication Title: 
Journal of Alternative and Complementary Medicine (New York, N.Y.)

INTRODUCTION: Traditional Chinese Medicine (TCM), a modern interpretation of Chinese medicine, developed in the 1950s. It differentiates biomedical diseases into patterns. Each pattern comprises symptom/signs that have their own unique treatment protocol. Most TCM research has used fixed formula treatments for Western-defined diseases with outcomes often measured using objective biomedical markers. More recently, a number of trials have attempted to accommodate TCM clinical practice within the framework of rigorous evidence-based medical research.

Author(s): 
Berle, Christine A.
Cobbin, Deirdre
Smith, Narelle
Zaslawski, Christopher
Publication Title: 
Chinese Journal of Integrative Medicine

Pattern diagnosis is an integral aspect of Chinese medicine (CM). CM differentiates biomedical diseases into patterns, based upon the patient's symptoms and signs. Pattern identification (PI) is used to diagnose, direct the treatment principle and determine the treatment protocol. Most CM research has used fixed formula treatments for Western-defined diseases with outcomes measured using objective biomedical markers. This article presents an innovative method used in a randomised controlled pilot study using acupuncture for participants with hepatitis C virus.

Author(s): 
Berle, Christine
Cobbin, Deirdre
Smith, Narelle
Zaslawski, Christopher
Publication Title: 
Liver International: Official Journal of the International Association for the Study of the Liver

BACKGROUND & AIMS: The prevention and control of HCV infection is complex and challenging in terms of describing risk factors and modes of transmission. This meta-analysis was conducted to summarize the best available data on HCV risk factors worldwide and in Egypt. METHODS: Through exhaustive literature searches (1989-2013) of HCV risk factors, 357 original eligible articles were included in this study.

Author(s): 
El-Ghitany, Engy Mohamed
Abdel Wahab, Moataza M.
Abd El-Wahab, Ekram W.
Hassouna, Safaa
Farghaly, Azza G.
Publication Title: 
Indian Journal of Pathology & Microbiology

BACKGROUND: Patients with thalassemia major are largely transfusion dependent and are thus exposed to a variety of risks such as transmission of infectious diseases, iron overload and alloimmunization. This study was performed to determine the prevalence of human immune deficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and red cell antibodies among multiple-transfused thalassemic patients in and around the national capital region.

Author(s): 
Makroo, Raj Nath
Arora, Jatinder Singh
Chowdhry, Mohit
Bhatia, Aakanksha
Thakur, Uday Kumar
Minimol, Antony
Publication Title: 
Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation

INTRODUCTION: Transplantation is a life-saving option for patients with liver disease. However, recovery is variable. Impairments in physical health, emotional wellbeing and quality of life are reported. Quality of life may be worse after transplantation for hepatitis C virus (HCV) infection. OBJECTIVE: To identify factors that could impact on quality of life after liver transplantation for HCV infection. METHODS: A qualitative design was used. Data were collected by in-depth interview. Colaizzi's framework for data analysis was used.

Author(s): 
Dudley, Tracey
Chaplin, Dawn
Clifford, Collette
Mutimer, David John
Publication Title: 
Sociology of Health & Illness

Drawing on qualitative interview accounts with people who have injected drugs, we deploy ideas of biological and therapeutic citizenship to explore how the negotiation of access to hepatitis C treatment enacts patient citizenship potential. We find that the patient citizenship made through hepatitis C treatment divides those who are deserving from those who are not, largely in relation to their presentations of self-control, responsibility and recovery regarding drug use.

Author(s): 
Rhodes, Tim
Harris, Magdalena
Martin, Anthea
Publication Title: 
Psychosomatics

This cross-sectional study examined the association between the severity of chronic hepatitis C and the type 1 personality, which has been shown by Grossarth-Maticek to be strongly related to the incidence of cancer and mortality.

Author(s): 
Nagano, Jun
Nagase, Shoji
Sudo, Nobuyuki
Kubo, Chiharu
Publication Title: 
Drug and Alcohol Dependence

BACKGROUND: A safe and efficacious vaccine may be the most efficient and cost-effective strategy for controlling the hepatitis C virus (HCV) epidemic among people who inject drugs (PWID) and several candidates are in development. However, little is known about the factors that influence willingness to participate (WTP) in candidate HCV vaccine trials among this group.

Author(s): 
Park, Ju Nyeong
White, Bethany
Bates, Anna
Enriquez, Jarliene
Liao, Len
Maher, Lisa
Publication Title: 
Acta Pharmacologica Sinica

Hepatitis B virus (HBV) or hepatitis C virus (HCV) infections are a major threat worldwide. Combination therapy of interferon-alpha and ribavirin is currently the treatment of choice for HCV-infected patients. However, this regimen is only effective in approximately 50% of patients and provokes severe side-effects. Numerous natural alternatives for treating HCV have been suggested. Deoxynojirimycin and its derivatives are iminosugars which exert anti-HCV activity by inhibiting alpha-glucosidases.

Author(s): 
Wohlfarth, Carolin
Efferth, Thomas

Pages

Subscribe to RSS - Hepatitis C